gmp guidelines Fundamentals Explained
No. 21 CFR 211.113(a) involves acceptable prepared processes for being recognized and followed for the duration of manufacturing to prevent objectionable microorganisms in drug products not required to be sterile. In addition, the second paragraph of USP General Chapter Antimicrobial Effectiveness Screening reads: Antimicrobial preservativ